Skip to content

In the BioHarmony Drug Report Database


Tpoxx (tecovirimat) is a small molecule pharmaceutical. Tecovirimat was first approved as Tpoxx on 2018-07-13. It is used to treat smallpox in the USA. Tpoxx's patents are valid until 2031-03-23 (FDA).
Trade Name Tpoxx
Common Name Tecovirimat
Indication smallpox
Drug Class Antivirals: antiviral, disrupts viral maturation
Get full access now